Valsts: Īrija
Valoda: angļu
Klimata pārmaiņas: HPRA (Health Products Regulatory Authority)
CITALOPRAM
B & S Healthcare
20 Milligram
Tablets
2006-08-25
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Cipramil 20 mg Film-coated Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 20mg citalopram (as hydrobromide). Excipients: Lactose _For a full list of excipients, see section 6.1._ 3 PHARMACEUTICAL FORM Film-coated tablet. _Product imported from the Netherlands and the UK:_ White, oval tablets deeply scored on one face, with the letters ‘C’ and ‘N’ on either side of the score. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Treatment of depressive illness in the initial phase and as maintenance against potential relapse/recurrence. Cipramil is also indicated in the treatment of panic disorder with or without agoraphobia. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION ADULTS Treating Depression Citalopram should be administered as a single oral dose of 20 mg daily. Dependent on individual patient response this may be increased to a maximum of 60 mg daily. The dose may be given in the morning or evening. A treatment period of at least 6 months is usually necessary to provide adequate maintenance against the potential for relapse. Treating Panic Disorder In common with other pharmacotherapy used in this patient group, a low starting dose is advised to reduce the likelihood of a paradoxical initial anxiogenic effect. A single dose of 10 mg daily is recommended for the first week before increasing the dose to 20 mg daily. The dose may be further increased, up to a maximum of 60 mg daily dependent on individual patient response; however an optimum dose of 20-30 mg daily was indicated in a clinical study. Maximum effectiveness of citalopram in treating panic disorder is reached after about 3 months and the response is maintained during continued treatment. Dependent on individual Izlasiet visu dokumentu